Asia-Pacific Healthcare Industry Shifts Focus to Preventive Medicine, Finds Frost & Sullivan
Wellness, nutraceuticals and health supplements make rapid headway into the mass market
KUALA LUMPUR, Malaysia, July 20, 2015 /PRNewswire/ -- As the integration of the Association of Southeast Asian Nations (ASEAN) Economic Community (AEC) fast-tracks intra-ASEAN trade, regulatory harmonization and free trade of goods will pave the way for opportunities worth US$160 billion in the Asia-Pacific healthcare industry by 2016. Digitization, decentralization and democratization of data will enable patients to take better responsibility of their health, widening scope in the preventive health and wellness markets.
New analysis from Frost & Sullivan, 2015 Asia-Pacific Healthcare Industry Outlook (https://www.frost.com/p85a), finds that companies will look to differentiate themselves through pricing, positioning and distribution channels in order to capitalize on the widespread demand for preventive healthcare. Consequently, wellness, nutraceuticals and health supplements will become a mass market phenomenon.
"Asian companies will strengthen their position and acquire larger market shares than multinational companies (MNCs), especially in the low- to mid-tier technology space," said Frost & Sullivan Healthcare Industry Manager Nitin Dixit. "The trend of private companies managing public hospitals and new private hospitals serving public insurance patients will gain traction in India, China and Indonesia."
Several factors will shape the Asia-Pacific healthcare industry over the next few years:
- To tackle corruption, countries in Asia-Pacific will introduce price transparency measures and innovative procurement models such as e-catalogues, which will help control medical device prices and generate healthy competition among suppliers
- IT adoption in primary and community care settings will increase, chiefly in Australia, Singapore, Malaysia and Japan
- Cell therapy, especially stem cell therapy for adult stem cells and embryonic stem cells, will be the most attractive market in South Korea and Japan
- MNCs will prioritize R&D and launch strategies for the Asia-Pacific market over the needs of markets in the West, primarily to fight challenges such as infectious diseases in the region
- Singapore is emerging as one of the most attractive hubs for biologics in Asia-Pacific
"International providers are establishing sales subsidiaries in Asia-Pacific countries to widen their operational reach," added Dixit. "Customizing products to cater to local market needs will be another crucial strategy for companies to bolster their standing in the Asia-Pacific healthcare industry."
For more information on this research, please email Donna Jeremiah, Corporate Communications, at [email protected].
2015 Asia-Pacific Healthcare Industry Outlook is part of the Connected Health (http://www.connectedhealth.frost.com) Growth Partnership Service program. Frost & Sullivan's related studies include: Healthcare IT Spending in Australia and Multi-parameter Patient Monitoring Market in Asia-Pacific, Global CRO Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
2015 Asia-Pacific Healthcare Industry Outlook
P85A-48
Contact:
Donna Jeremiah
Corporate Communications – Asia Pacific
P: +61 (02) 8247 8927
F: +61 (02) 9252 8066
E: [email protected]
Carrie Low
Corporate Communications – Asia Pacific
P: +603 6204 5910
F: +603 6201 7402
E: [email protected]
Melissa Tan
Corporate Communications – Asia Pacific
P: +65 6890 0926
F: +65 6890 0999
E: [email protected]
Twitter: @FrostSullivanAP
Facebook: FrostandSullivan
Linkedin: http://bit.ly/FrostSullivanAPAC
SOURCE Frost & Sullivan
Share this article